All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional
A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood
At a glance
Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Boehringer Ingelheim International GmbH
Enrolment target
16
Start
19 Jul 2023
Who may be eligible?
Age 18 Years to any · Sex: Male
Locations (1)
- —Germany
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.